The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Khaĭrutdinov E.R.

Kafedra gospital'noĭ khirurgii RUDN, Moskva;
NUZ TsKB #2 im. N.A. Semashko OAO "RZhD", Moskva

Shugushev Z.Kh.

Department of Cardiovascular Surgery, Peoples’ Friendship University of Russia, Moscow, Russia

Maksimkin D.A.

Central Town Clinical Hospital, Reutov, Moscow Region, Department of Cardiovascular Surgery, Peoples’ Friendship University of Russia, Moscow, Russia, Clinic for Aortic and Cardiovascular Surgery, I.M. Sechenov First Moscow State Medical University

Faĭbushevich A.G.

Kafedra gospital'noĭ khirurgii RUDN, Moskva;
NUZ TsKB #2 im. N.A. Semashko OAO "RZhD", Moskva

Bazanov I.S.

Kafedra gospital'noĭ khirurgii RUDN, Moskva;
NUZ TsKB #2 im. N.A. Semashko OAO "RZhD", Moskva

Osmonaliev K.Zh.

Kafedra gospital'noĭ khirurgii RUDN, Moskva;
NUZ TsKB #2 im. N.A. Semashko OAO "RZhD", Moskva

Tarichko Iu.V.

Kafedra gospital'noĭ khirurgii s kursom detskoĭ khirurgii RUDN, Moskva

Immediate results of endovascular treatment in patients with multivessel coronary heart disease

Authors:

Khaĭrutdinov E.R., Shugushev Z.Kh., Maksimkin D.A., Faĭbushevich A.G., Bazanov I.S., Osmonaliev K.Zh., Tarichko Iu.V.

More about the authors

Read: 907 times


To cite this article:

Khaĭrutdinov ER, Shugushev ZKh, Maksimkin DA, Faĭbushevich AG, Bazanov IS, Osmonaliev KZh, Tarichko IuV. Immediate results of endovascular treatment in patients with multivessel coronary heart disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2012;5(2):18‑23. (In Russ.)

Recommended articles:
Radionuclide methods in analysis of myocardial perfusion and meta­bolic acti­vity. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(4):12-19
Reclassification of ischemic heart disease epidemiological criteria. Russian Journal of Preventive Medi­cine. 2024;(12):61-68

References:

  1. Belenkov Yu.N., Akchurin R.S., Savchenko A.P. i dr. Rezul'taty koronarnogo stentirovaniya i khirurgicheskogo lecheniya u bol'nykh IBS s mnogososudistym porazheniem koronarnogo rusla. Kardiologiya 2002; 5: 42-45.
  2. Ambrose J.A., Winters S.L., Arrora R.R. et al. Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol 1985; 6: 1233-1238.
  3. Bourassa M.G., Holubkov R., Yeh W. et al. Strategy of complete revascularization in patients with multivessel coronary artery disease (a report from the 1985-1986 NHLBI PTCA Registry). Am J Cardiol 1992; 70: 174.
  4. Bourassa M.G., Yeh W., Holubkov R. et al. Long-term outcome of patients with incomplete vs complete revascularization after multivessel PTCA (a report from NHLBI PTCA Registry). Eur Heart J 1998; 19: 103-111.
  5. Buda A.J., Macdonald I.L., Anderson M.J. et al. Long-term results following coronary bypass operation: importance of preoperative factors and complete revascularization. J Thorac Cardiovasc Surg 1981; 82: 383-290.
  6. Chung C., Nakamura S., Tanaka K. et al. Effect of recanalization of CTO on global and regional LV function in pts with/without previous MI. Catheter Cardiovasc Int 2003; 60: 368-374.
  7. Faxon D.P., Ghalilli K., Jacobs A.K. The degree of revascularization and outcome after multivessel coronary angoplasty. Am Heart J 1992; 123: 854-859.
  8. Hannan E.L., Racz M., Holmes D.R. et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 2006; 113; 2406-2412.
  9. Hannan E.L., Wu C., Walford G. et al. Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes. J Am Coll Cardiol Intv 2009; 2: 17-25.
  10. Ijsselmuiden A.J.J., Ezechiels J.P., Westendorp I.C.D. et al. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison. Am Heart J 2004; 148: 467-474.
  11. Jones E.L., Craver J.M., Guyton R.A. et al. Importance of complete revascularization in performance of the coronary bypass operation. Am J Cardiol 1983; 51: 7-12.
  12. Martuscelli E., Clementi F., Gallagher M.M. et al. Revascularization strategy in patients with multivessel disease and a major vessel chronically occluded; data from the CABRI trial. Eur J Card Thorac Surg 2008; 33: 4-8.
  13. Ong A.T.L., Serruys P.W. Coronary artery bypass graft surgery versus percutaneous coronaryintervention. Circulation 2006; 114: 249-255.
  14. Patil C.V., Nikolsky E., Boulos M. et al. Multivessel coronary artery disease: current revascularization strategies. Eur Heart J 2001; 22: 1183-1197.
  15. Pijls N.H.J., Fearon W.F., Tonino P.A.L. et al. Fractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: 2-Year Follow-Up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study. J Am Coll Cardiol 2010; 56; 177-184.
  16. Pijls N.H., van Schaardenburgh P., Manoharan G. et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 2007; 49: 2105-2111.
  17. Rodriguez A.E., Maree A.O., Grinfeld L. et al. Revascularization strategies of coronary multiple vessel disease in drug eluting stent era: one year follow-up results of ERACI III trial. Eurointervention 2006; 2: 53-60.
  18. Rodriguez A.E., Maree A.O., Mieres J. et al. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry. Eur Heart J 2007; 28: 2118-2125.
  19. Serruys P.W., Donohoe D.J., Wittebols K. et al. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II). Eur Heart J 2007; 28: 4: 433-442.
  20. Serruys P.W., Morice M.C., Kappetein A.P. et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
  21. Serruys P.W., Ong A.T.L., Morice M.-C. et al. Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novocoronary artery lesions. Euro Interv 2005; 2: 147-156.
  22. Serruys P.W., Onuma Y., Garg S. et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention 2009; 5: 1: 50-56.
  23. Silber S., Albertsson P., Aviles F.F. et al. Guidelines for percutaneous coronary interventions. Eur Heart J 2005; 26: 804-847.
  24. Shaw L.J., Berman D.S., Maron D.J. et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008; 117: 1283-1291.
  25. Topol E.J. Textbook of interventional cardiology. 2008; 417-430.
  26. van den Brand M.J.B.M., Rensing B.J.W.M., Morel M.M. et al. The effect of completeness of revascularization on event-free survival at one year in the arts trial. J Am Coll Cardiol 2002; 39: 559-564.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.